Flex Appoints Dr. Todd M. Fruchterman as President, Reliability Solutions Segment
November 23 2020 - 9:05AM
Business Wire
Flex (NASDAQ: FLEX) announced the appointment of Dr. Todd M.
Fruchterman as president of the Reliability Solutions segment,
effective November 30, 2020. As part of the company’s succession
planning, Dr. Fruchterman’s appointment follows Paul Humphries’s
notice of his retirement, effective November 30, 2020 with a
transition period ending March 31, 2021.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20201123005639/en/
Dr. Todd M. Fruchterman joins Flex as
President, Reliability Solutions segment (Photo: Business Wire)
Dr. Fruchterman brings a wealth of experience to his role at
Flex with deep knowledge in regulated businesses. He will oversee
the company’s Reliability Solutions segment comprised of the
Automotive, Health Solutions and Industrial business units. He will
be responsible for driving the segment’s strategy to accelerate
growth, expand design-led engagements and capitalize on the
synergies across the organization.
Most recently, Dr. Fruchterman was the president & general
manager of Medical Solutions at 3M Company, the largest division in
the company, where he delivered transformational acquisitions and
global above-market, profitable growth. Over his nine plus year
tenure at 3M, he held multiple roles, including president of
Critical and Chronic Care Solutions, and senior vice president of
R&D and Regulatory Affairs, chief technology officer (CTO)
& chief medical officer (CMO) of 3M Health Care, where he was
also a member of the Corporate Technical Operating Committee. Prior
to joining 3M, Dr. Fruchterman was executive vice president, CTO
and CMO at Kinetic Concepts, Inc., in San Antonio, Texas. In his
23-year career, he has also held various positions at Johnson &
Johnson, including leading worldwide biosurgical R&D for the
Ethicon division; Schering-Plough Corporation, where he directed
medical and strategic marketing for the hepatitis business; and
Response Genetics, Inc., where he held the positions of president,
chief executive officer and chief operating officer. Dr.
Fruchterman received his Bachelor of Arts in Biological Basis of
Behavior and Medical Doctorate degrees from the University of
Pennsylvania, and his Ph.D. in Physiology and Biophysics from the
University of Louisville, Kentucky.
“On behalf of our employees at Flex and our Board of Directors,
I want to thank Paul for his contributions during his 21-year
career at the company and wish him the very best in his
retirement,” said Revathi Advaithi, CEO at Flex.
Advaithi continued, “At Flex, our Reliability Solutions segment,
now more than ever during the COVID-19 pandemic, plays a critical
role in delivering essential products that create value and improve
people’s lives. I’m delighted to welcome Todd to the team. I am
confident that with his experience managing large, regulated
businesses, he will build on our long-term strategy to drive
profitable growth through differentiated technology and
manufacturing expertise for our Reliability businesses.”
About Flex
Flex (Reg. No. 199002645H) is the manufacturing partner of
choice that helps a diverse customer base design and build products
that improve the world. Through the collective strength of a global
workforce across 30 countries and responsible, sustainable
operations, Flex delivers technology innovation, supply chain, and
manufacturing solutions to diverse industries and end markets. For
more information, visit flex.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201123005639/en/
Media & Press Silvia Gianelli
Senior Director, Corporate Communications (408) 797-7130
Silvia.Gianelli@flex.com
Investors & Analysts David
Rubin Vice President, Investor Relations (408) 577-4632
David.Rubin@flex.com
Flex (NASDAQ:FLEX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Flex (NASDAQ:FLEX)
Historical Stock Chart
From Jul 2023 to Jul 2024